Impact Of Bronchoscopy After First-Line Chemotherapy In Patients With Stage Iv Non Small Cell Lung Cancer On Overall Survival

被引：0
|
作者：
Dayen, C. [1 ]
Trouve, C. [1 ]
Poulet, C. [2 ]
Gubler, B.
Sevestre, H. [3 ]
Suguenot, R. [1 ]
Bentayeb, H. [1 ]
Rault, I. [1 ]
Lecuyer, E. [1 ]
Hoguet, E. [4 ]
Le Meunier, F. [1 ]
Jounieaux, V. [2 ]
Benzerdjeb, N. [3 ]
Andrejak, C. [1 ]
Douadi, Y. [1 ]
机构：
[1] CHG St Quentin, St Quentin en Yvelines, France
[2] Pneumol Unit, Amiens, France
[3] Pathol Unit, Amiens, France
[4] CH Abbeville, Pneumol Unit, Abbeville, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3397
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Overall survival of adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line treatment for extensive-stage small cell lung cancer
    Chen, Dawei
    Gao, Aiqin
    Zou, Bing
    Huang, Wei
    Shao, Qian
    Meng, Xiangjiao
    Zhang, Pinliang
    Tang, Xiaoyong
    Hu, Xudong
    Zhang, Yan
    Guo, Jun
    Zhao, Wei
    Fu, Lei
    Zhao, Changhong
    Yuan, Jiajia
    Yu, Jinming
    Wang, Linlin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Phase II trial of first-line gefitinib in patients unsuitable for chemotherapy with stage II/IV non-small-cell lung cancer.
    Swinson, D
    Williams, S
    Beddard, K
    Price, L
    Reaper, L
    Cullen, MH
    Ferry, DR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 684S - 684S
  • [23] Hycamtin - For progressive small cell lung cancer after first-line chemotherapy
    不详
    FORMULARY, 1999, 34 (03) : 190 - 191
  • [24] Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients
    Oku, Yuka
    Toyokawa, Gouji
    Wakasu, Sho
    Kinoshita, Fumihiko
    Takamori, Shinkichi
    Watanabe, Kenji
    Haratake, Naoki
    Nagano, Taichi
    Kosai, Keisuke
    Takada, Kazuki
    Fujimoto, Airi
    Higashijima, Kodo
    Shiraishi, Yoshimasa
    Tanaka, Kentaro
    Takeoka, Hiroaki
    Okamoto, Masaki
    Yamashita, Takanori
    Shimokawa, Mototsugu
    Shoji, Fumihiro
    Yamazaki, Koji
    Okamoto, Tatsuro
    Seto, Takashi
    Ueda, Hitoshi
    Takeo, Sadanori
    Nakashima, Naoki
    Okamoto, Isamu
    Takenaka, Tomoyoshi
    Yoshizumi, Tomoharu
    CANCER MEDICINE, 2023, 12 (13): : 14327 - 14336
  • [25] Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small cell lung cancer patients
    Takamori, S.
    Oku, Y.
    Toyokawa, G.
    Wakasu, S.
    Kinoshita, F.
    Watanabe, K.
    Haratake, N.
    Nagano, T.
    Kosai, K.
    Shiraishi, Y.
    Yamashita, T.
    Shimokawa, M.
    Shoji, F.
    Yamazaki, K.
    Okamoto, T.
    Seto, T.
    Takeo, S.
    Nakashima, N.
    Okamoto, I.
    Takenaka, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S60 - S60
  • [26] Stage III-IV non small cell lung cancer: the impact of SUVmax and %ΔSUVmax in predicting survival after chemotherapy
    Cistaro, A.
    Quartuccio, N.
    Mojtahedi, A.
    Fania, P.
    Cucinotta, M.
    Campenni, A.
    Ficola, U.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S466 - S466
  • [27] Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy
    Morgensztern, Daniel
    Ko, Amy
    O'Brien, Mary
    Ong, Teng Jin
    Waqar, Saiama N.
    Socinski, Mark A.
    Postmus, Pieter E.
    Bhore, Rafia
    CANCER, 2019, 125 (14) : 2394 - 2399
  • [28] Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer (NSCLC) patients (pts) treated with first-line chemotherapy
    Brady, Anna K.
    McNeill, Jonathan D.
    Judy, Brendan
    Evans, Tracey L.
    Cohen, Roger B.
    Langer, Corey J.
    Vachani, Anil
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Temporal Trend of Overall Survival in Patients with Advanced Non-small Cell Lung Cancer Given First-Line Cytotoxic Treatments
    Andrea Messori
    Dario Maratea
    Valeria Fadda
    Sabrina Trippoli
    Lung, 2012, 190 : 591 - 592
  • [30] Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer
    Spence, Michele M.
    Hui, Rita L.
    Chang, Jennifer T.
    Schottinger, Joanne E.
    Millares, Mirta
    Rashid, Nazia
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (02): : 159 - 159
12345